Microcap bought in CVR deal - stock is up 700%
|
10
|
Resverlogix Corp.
|
Sep 20, 2016 12:50PM
|
Re: Leading From Behind
|
10
|
Resverlogix Corp.
|
Oct 13, 2020 04:41PM
|
Abstract - first example of a "curative" effect?
|
10
|
Resverlogix Corp.
|
Oct 10, 2018 05:28PM
|
Re: RVX announces first right of refusal for license deal in the US
|
10
|
Resverlogix Corp.
|
Oct 24, 2017 05:05PM
|
Re: RVX Announces Update Webcast and Conference Call
|
10
|
Resverlogix Corp.
|
Jan 18, 2021 01:26PM
|
BD2 specific inhibitors mentioned in Science
|
9
|
Resverlogix Corp.
|
Mar 22, 2020 06:53AM
|
Re: The BET Protein Inhibitor Apabetalone Rescues Diabetes-induced Impairment of Angiogenic Response by Epigenetic Regulation of Thrombospondin-1
|
9
|
Resverlogix Corp.
|
Dec 16, 2021 02:26PM
|
Civil vs. criminal court judgments
|
9
|
Resverlogix Corp.
|
Dec 17, 2019 10:03AM
|
IP considerations may prevent RVX from disclosing eGFR data
|
9
|
Resverlogix Corp.
|
Jun 08, 2020 03:35PM
|
Re: Their finest hour
|
9
|
Resverlogix Corp.
|
Sep 24, 2019 04:02PM
|
Re: Lower LDL-C and Increased Type 2 Diabetes Risk - Bear
|
9
|
Resverlogix Corp.
|
Jun 06, 2020 02:14PM
|
Re: Not good for the potential of apabetalone as a Covid-19 therapy
|
9
|
Resverlogix Corp.
|
Nov 29, 2021 06:14PM
|
If anyone still cares about science...
|
9
|
Resverlogix Corp.
|
Oct 09, 2020 04:38PM
|
Re: Questions for Q1 webcast
|
8
|
Resverlogix Corp.
|
Mar 18, 2016 06:13PM
|
Re: Our own BKC on the webcast
|
8
|
Resverlogix Corp.
|
Feb 04, 2021 12:49PM
|
Yet another potential indication: Reduction of drug-seeking behavior
|
8
|
Resverlogix Corp.
|
Oct 26, 2021 03:12PM
|
Impact factors
|
8
|
Resverlogix Corp.
|
Apr 16, 2019 03:31AM
|
Re: Not good for the potential of apabetalone as a Covid-19 therapy
|
8
|
Resverlogix Corp.
|
Nov 29, 2021 05:46PM
|
Re: 2% market penetration
|
8
|
Resverlogix Corp.
|
Nov 17, 2017 05:00PM
|
Please don't...
|
8
|
Resverlogix Corp.
|
Feb 27, 2017 11:17AM
|